Mandated quality measures and economic implications of venous thromboembolism prevention and management

American Journal of Surgery

Volumn 199, Issue 1, 2010, Pages S21-S31

  Passman, Marc A ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; EVIDENCE BASED PRACTICE; HEALTH CARE COST; HEALTH CARE FINANCING; HEALTH CARE QUALITY; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; SYSTEMATIC REVIEW; THROMBOSIS PREVENTION; TOTAL QUALITY MANAGEMENT; VENOUS THROMBOEMBOLISM; ACCREDITATION; ECONOMICS; HEALTH EDUCATION; HOSPITALIZATION; LUNG EMBOLISM; POSTOPERATIVE COMPLICATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; UNITED STATES;

ANTICOAGULANT AGENT;

ANTICOAGULANTS; HEALTH EDUCATION; HOSPITALIZATION; HUMANS; JOINT COMMISSION ON ACCREDITATION OF HEALTHCARE ORGANIZATIONS; POSTOPERATIVE COMPLICATIONS; PULMONARY EMBOLISM; QUALITY ASSURANCE, HEALTH CARE; RISK ASSESSMENT; RISK FACTORS; UNITED STATES; VENOUS THROMBOEMBOLISM;

EID: 77649194243     PISSN: 00029610     EISSN: 18791883     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2009.10.005     Document Type: Article

References (43)

1. US Department of Health and Human Services. The Surgeon General's Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. 2008. http://www.surgeongeneral.gov/topics/deepvein Accessed: June 12, 2009.
2. Geerts, W.H., Bergqvist, D., Pineo, G.F., et al. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 133 (2008), 381S–453S.
3. Goldhaber, S.Z., Tapson, V.F., DVT Free Steering Committee. A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol 93 (2004), 259–262.
4. Anderson, F.A., Wheeler, H.B., Goldberg, R.J., et al. Physician practices in the prevention of venous thromboembolism. Ann Intern Med, 115, 1991, 591.
5. Tapson, V.F., Decousus, H., Pini, M., et al. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on venous thromboembolism. Chest 132 (2007), 936–945.
6. Stratton, M.A., Anderson, F.A., Bussey, H.I., et al. Prevention of venous thromboembolism: adherence to the 1995 American College of Chest Physicians consensus guidelines for surgical patients. Arch Intern Med 160 (2000), 334–340.
7. Cohen, A.T., Tapson, V.F., Bergmann, J.F., et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 371 (2008), 387–394.
8. Clagett, G.P., Anderson, F.A. Jr, Heit, J., et al. Prevention of venous thromboembolism. Chest 108 (1995), 312S–334S.
9. Geerts, W.H., Pineo, G.F., Heit, J.A., et al. Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126 (2004), 338S–400S.
10. Kohn, K.T., To Err Is Human: Building a Safer Health System. 1999, National Academy Press, Washington, DC.
11. National Quality Forum. Safe Practices for Better Health Care: A Consensus Report. 2003, National Quality Forum, Washington, DC.
12. National Quality Forum. National Voluntary Consensus Standards for Prevention and Care of Venous Thromboembolism: Policy, Preferred Practices, and Initial Performance Measures—A Consensus Report. 2006, National Quality Forum, Washington, DC.
13. National Quality Forum. National Voluntary Consensus Standards for Prevention and Care of Venous Thromboembolism: Additional Performance Measures—A Consensus Report. 2008, National Quality Forum, Washington, DC.
14. National Quality Forum. Safe Practices for Better Healthcare; 2009 Update: A Consensus Report. 2009, National Quality Forum, Washington, DC.
15. Haralson, R.H., Clearing up the confusion with VTE and/or PE prophylaxis guidelines. AAOS 2008. http://www.aaos.org/news/aaosnow/jan08/clinical2.asp Accessed: June 1, 2009.
16. Surgical Care Improvement Project. VTE prophylaxis pocket card. April 2009. http://www.qualitynet.org/dcs/ContentServer?cid=1176726306714&pagename=Medqic%2FMQTools%2FToolTemplate&c=MQTools Accessed: June 24, 2009.
17. Surgical Care Improvement Project. Specifications manual for national hospital inpatient quality measures, version 3.0. May 2009. Available from: http://www.qualitynet.org/dcs/ContentServer?c=Page&pagename=QnetPublic%2FPage%2FQnetTier4&cid=1228695698425. Accessed: June 24, 2009.
18. Shojania K, Duncan B, McDonald K, et al. Making Health Care Safer: A Critical Analysis of Patient Safety Practices. AHRQ publication 01-E058. Rockville, MD: Agency for Healthcare Research and Quality.
19. Maynard, G., Stein, J., Preventing Hospital-Acquired Venous Thromboembolism: A Guide for Effective Quality Improvement. 2008, Agency for Healthcare Research and Quality, AHRQ publication 08-0075. Rockville, MD.
20. Schünemann, H., Cook, D., Grimshaw, J., et al. Antithrombotic and thrombolytic therapy: from evidence to application. The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126:Suppl (2004), 688S–696S.
21. McMullin, J., Cook, D., Griffith, L., et al. Minimizing errors of omission: behavioural reenforcement of heparin to avert venous emboli: the BEHAVE study. Crit Care Med 34 (2006), 694–699.
22. Timmons, S., O'Callaghan, C., O'Connor, M., et al. Audit-guided action can improve the compliance with thromboembolic prophylaxis prescribing to hospitalized, acutely ill older adults. J Thromb Haemost 3 (2005), 2112–2113.
23. Mosen, D., Elliott, C., Egger, M., et al. The effect of a computerized reminder system on the prevention of postoperative venous thromboembolism. Chest 125 (2004), 1635–1641.
24. Kucher, N., Koo, S., Quiroz, R., et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med 352 (2005), 969–977.
25. Tooher, R., Middleton, P., Pham, C., et al. A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals. Ann Surg 241 (2005), 397–415.
26. Michota, F., Bridging the gap between evidence and practice in venous thromboembolism prophylaxis: the quality improvement process. J Gen Intern Med 22 (2007), 1762–1770.
27. Anticoagulation therapy for venous thromboembolism. Medscape Gen Med 2004;6:5. Available from: http://www.medscape.com/viewarticle/487577. Accessed: June 24, 2009.
28. Heit, J.A., Cohen, A.T., Anderson, F.A. Jr, VTE Impact Assessment Group. Estimated annual number of incident and recurrent, non-fatal and fatal venous thromboembolism (VTE) events in the US (abstr). Blood, 106, 2005, 910.
29. MacDougall, D., Feliu, A., Boccuzzi, S., et al. Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome. Am J Health Syst Pharm 63:Suppl 6 (2006), S5–S15.
30. Dimick, J., Chen, S., Taheri, P., et al. Hospital costs associated with surgical complications: a report from the private-sector National Surgical Quality Improvement Program. J Am Coll Surg 199 (2004), 531–537.
31. Hansson, P., Sörbo, J., Eriksson, H., Recurrent venous thromboembolism after deep vein thrombosis incidence and risk factors. Arch Intern Med 160 (2000), 769–774.
32. Cushman, M., Tsai, A., White, R., et al. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med 117 (2004), 19–25.
33. Heit, J., Mohr, D., Silverstein, M., et al. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med 160 (2000), 761–768.
34. Spyropoulos, A., Lin, J., Direct medical costs of venous thromboembolism and subsequent hospital readmission rates: an administrative claims analysis from 30 managed care organizations. J Manag Care Pharm 13 (2007), 475–486.
35. Bergmann, J., Neuhart, E., A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness: The Enoxaparin in Medicine Study Group. Thromb Haemost, 76, 1996, 529.
36. Harenberg, J., Roebruck, P., Heene, D., Heparin Study in Internal Medicine Group: Subcutaneous low-molecular-weight heparin versus standard heparin and the prevention of thromboembolism in medical inpatients. Haemostasis 26 (1996), 127–139.
37. Lechler, E., Schramm, W., Flosbach, C., The Prime Study Group: The venous thrombotic risk in non-surgical patients: epidemiological data and efficacy/safety profile of a low-molecular-weight heparin (enoxaparin). Haemostasis, 26, 1996, 49.
38. Kleber, F., Witt, C., Vogel, G., et al. The-Prince Study Group: Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease. Am Heart J 145 (2003), 614–621.
39. Samama, M., Cohen, A., Darmon, J., et al. Prophylaxis in Medical Patients With Enoxaparin Study Group: A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. N Engl J Med 341 (1999), 793–800.
40. Warkentin, T.E., Levine, M.N., Hirsh, J., et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 332 (1995), 1330–1335.
41. Spyropoulos, A.C., Outpatient-based treatment protocols in the management of venous thromboembolic disease. Am J Manag Care 6 (2000), S1034–S1044.
42. Deitelzweig, S.B., Becker, R., Lin, J., et al. Comparison of the two-year outcomes and costs of prophylaxis in medical patients at risk of venous thromboembolism. Thromb Haemost 100 (2008), 810–820.
43. Lundkvist, J., Bergqvist, D., Jonsson, B., Cost-effectiveness of extended prophylaxis with fondaparinux compared with low molecular weight heparin against venous thromboembolism in patients undergoing hip fracture surgery. Eur J Health Econ 8 (2007), 313–323.